Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Proactive research analyst says Tiziana Life Sciences "moving forward quite nicely"

By: News Direct

--News Direct--

Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a 2023 Clinical Outlook for clinical stage biotechnology company Tiziana Life Sciences Ltd (NASDAQ: TLSA). He gives his take on what the market can expect from the business this year, saying that it is now "moving forward quite nicely."

Contact Details

Proactive UK Ltd

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/proactive-research-analyst-says-tiziana-life-sciences-moving-forward-quite-nicely-546792176

Recent Quotes

View More
Symbol Price Change (%)
AMZN  227.35
+3.14 (1.40%)
AAPL  265.85
+3.03 (1.15%)
AMD  254.37
+1.45 (0.57%)
BAC  52.87
+0.30 (0.56%)
GOOG  267.63
+7.12 (2.73%)
META  750.68
+12.32 (1.67%)
MSFT  531.74
+8.13 (1.55%)
NVDA  190.94
+4.68 (2.51%)
ORCL  282.18
-1.15 (-0.41%)
TSLA  456.67
+22.95 (5.29%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.